Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B

NCT01395810 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01395810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01395810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
April 15, 2012
Completion date
March 30, 2014
Enrollment
71 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia b